Attached files

file filename
8-K - FORM 8-K - IMAX CORPd546769d8k.htm

IMAX CORPORATION

Exhibit 99.1

 

LOGO

IMAX CORPORATION

2525 Speakman Drive

Mississauga, Ontario, Canada L5K 1B1

Tel: (905) 403-6500 Fax: (905) 403-6450

www.imax.com

IMAX CORPORATION REPORTS FIRST-QUARTER 2018 RESULTS

HIGHLIGHTS

 

    Delivered Q1 2018 net income and adjusted net income of $8.5 million and $13.4 million, respectively, compared to Q1 2017 net income and adjusted net income of $0.1 million and $3.9 million, respectively.

 

    Achieved Q1 2018 earnings per share and adjusted earnings per share of $0.13 and $0.21, respectively compared to $nil and $0.06, respectively in Q1 2017.

 

    Adjusted EBITDA per Credit Facility was $31.4 million, up 70% compared to the same period last year.

 

    Gross Profit of $50.7 million, resulted in gross margins of 60%, a 750-basis point increase versus Q1 2017.

 

    Global IMAX box office of $246.9 million helped drive total revenues to $85.0 million, up 24% from the prior year period.

 

    Repurchased $13.4 million of shares at an average price of $20.46 per share.

 

    Successfully launched IMAX with Laser, the Company’s next-generation laser experience, bolstered by over 150 signings to date

 

    Avengers: Infinity War, the first commercial film shot entirely with IMAX cameras, kicked off the summer blockbuster season, delivering a record $41.5 million in opening weekend IMAX box office

NEW YORK – May 1, 2018 – IMAX Corporation (NYSE:IMAX) today reported first-quarter 2018 revenues of $85.0 million, gross profit of $50.7 million and net income attributable to common shareholders of $8.5 million, which calculates to $0.13 per diluted share. Adjusted net income attributable to common shareholders for the first quarter was $13.4 million, which calculates to $0.21 per diluted share. Adjusted EBITDA per Credit Facility was $31.4 million. For reconciliations of reported results to non-GAAP financial results, and for the definition and reconciliation of Adjusted EBITDA per Credit Facility, please see the end of this press release.

“Our first quarter results were strong from both a financial and strategic standpoint. We modified our programming strategy, demonstrated operating leverage and set the table for the successful launch of IMAX with Laser, which was bolstered by over 150 signings to date,” said Richard L. Gelfond, IMAX CEO. “In addition to benefitting from the revenue and cost initiatives we implemented last year—which helped drive Adjusted EBITDA growth of 70%, compared to Q1 last year—our recent performance also reflects IMAX’s growing value proposition to content-creators and moviegoers alike. As content-creators emphasize blockbuster-type content and as consumers seek differentiated moviegoing experiences, The IMAX Experience® is becoming an increasingly important platform to launch and experience global franchise content.” Gelfond concluded, “We believe our global footprint, coupled with our focus on creating differentiated experiences for the biggest cinematic releases, uniquely positions IMAX to benefit from these trends.”

First-Quarter 2018 Results

Network Update

During the quarter, the Company installed 16 theater systems, all of which were for new theater locations. The total IMAX® theater network consisted of 1,382 systems as of March 31, 2018, of which 1,286 were in commercial multiplexes. There were 529 theaters in backlog as of March 31, 2018, compared to the 524 in backlog as of March 31, 2017.

 

1


IMAX signed contracts for 45 new theaters across 8 countries in the first quarter of 2018. For a breakdown of theater system signings, installations, network and backlog by type for the first quarter of 2018, please see the end of this press release.

Box Office Update

Gross box office from IMAX DMR® films increased 16.4% to $246.9 million in the first quarter of 2018 from $212.1 million in the first quarter of 2017. Gross box office was generated primarily by the exhibition of 22 films (14 new and 8 carryovers), as compared to 18 films (12 new and 6 carryovers) exhibited in the first quarter of 2017.

First-Quarter Consolidated Results

The gross margin across all segments in the first quarter of 2018 was $50.7 million, or 59.6% of total revenues, compared to $35.8 million, or 52.1% of total revenues, in the first quarter of 2017. Operating expenses (which includes SG&A, excluding stock-based compensation, plus R&D) were $27.3 million in the quarter, down 9% compared to $30.0 million in the first quarter of 2017.

“Looking ahead, our objectives this year are focused on improving the earnings power of our core business, increasing the differentiation of The IMAX Experience relative to other moviegoing options, and reinforcing the strength of our brand amongst worldwide consumers.” Gelfond continued, “We believe these initiatives, coupled with our continued signings and installation momentum, should create meaningful value across the IMAX ecosystem. Moreover, we’re encouraged by the exciting upcoming film slate, the successful launch of IMAX with Laser and our continued focus on controlling costs.”

FASB ASC Topic 606 Revenue Recognition

As a result of adopting ASC Topic 606 regarding changes to revenue recognition, the Company recognized an additional $0.7 million of net incremental revenue in the first quarter of 2018. Additional details related to these revenue recognition changes can be found in our 10-Q document.

First-Quarter Segment Results

Network Business

 

    Network business revenues were $44.9 million in the quarter, compared with $39.3 million in the prior-year period. Gross margin for the network business were 70.2% in the most recent quarter, compared to 72.2% in the prior-year period.

 

    IMAX DMR revenues were $27.1 million in the first quarter of 2018, compared to $23.4 million in the first quarter of 2017. Gross margin for the IMAX DMR segment was 69.4%, compared to 74.6% in the prior-year comparative period. The lower margins in the recent quarter reflect increased marketing costs versus last year.

 

    Revenue from joint revenue-sharing arrangements were $17.9 million in the quarter, compared with $15.2 million in the prior-year period. Gross margin for joint revenue-sharing arrangements was 71.3%, compared to 67.3% in the prior-year comparative period.

Theater Business

 

    Theater business segment revenues were $35.0 million in the quarter, compared with $23.2 million in the prior-year comparative period, primarily reflecting the installation of 7 additional sales-type theaters.

 

    Gross margin on sales and sales-type leases was 64.0% compared with 46.4% in the year-ago period. The increase in the recent period is primarily the result of higher average margin per new system and no upgraded systems in the first quarter of 2018 versus 1 upgrade in 2017.

Supplemental Materials

For more information about the Company’s results, please refer to the IMAX Investor Relations website located at investors.imax.com.

 

2


Investor Relations Website and Social Media

On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at www.imax.com/content/investor-relations. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag. In addition, the Company maintains a Twitter account: @IMAX_Investors. The Company intends to use Twitter to disclose the box office information, as well as other information that may be of interest to the Company’s investor community.

The information posted on the Company’s website and/or via its Twitter account may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company’s website and its Twitter account in addition to the Company’s press releases, SEC filings and public conference calls and webcasts.

Conference Call

The Company will host a conference call today at 8:30AM ET to discuss its first quarter and 2018 financial results. This call is being webcast by Nasdaq and can be accessed at investors.imax.com. To access the call via telephone, interested parties in the US and Canada should dial (800) 289-0438 approximately 5 to 10 minutes before the call begins. Other international callers should dial (647) 484-0478. The conference ID for the call is 9118022. A replay of the call will be available via webcast at investors.imax.com or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 9118022.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX theaters to connect with audiences in extraordinary ways, and, as such, IMAX’s network is among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of March 31, 2018, there were 1,382 IMAX theater systems (1,286 commercial multiplexes, 12 commercial destinations, 84 institutional) operating in 77 countries. On Oct. 8, 2015, shares of IMAX China, a subsidiary of IMAX Corp., began trading on the Hong Kong Stock Exchange under the stock code “HK.1970.”

IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

###

This press release contains forward looking statements that are based on IMAX management’s assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, references to future capital expenditures (including the amount and nature thereof), business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the “Company”) and expectations regarding the Company’s future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company’s growth and operations in China; the performance of IMAX DMR films; the signing of theater system agreements; conditions,

 

3


changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates; competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks relating to recent consolidation among commercial exhibitors and studios; risks related to new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security; risks related to the Company’s inability to protect the Company’s intellectual property; general economic, market or business conditions; the failure to convert theater system backlog into revenue; changes in laws or regulations; the failure to fully realize the projected cost savings and benefits from the Company’s restructuring initiative; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

For additional information please contact:

 

Investors:

 

Michael K. Mougias, New York

212-821-0187

mmougias@imax.com

 

Business Media:

 

Sloane & Company, New York

Whit Clay

212-446-1864

wclay@sloanepr.com

  

Media:

 

IMAX Corporation, New York

Adam Davis

212-821-0116

adavis@imax.com

 

Entertainment Media:

 

Principal Communications Group, Los Angeles

Melissa Zuckerman/Paul Pflug

323-658-1555

melissa@pcommgroup.com

paul@pcommgroup.com

 

4


Additional Information

Signings and Installations

March 31, 2018

 

     Three Months
Ended March 31,
 
     2018     2017  

Theater Signings:

    

Full new sales and sales-type lease arrangements

     15       36  

New traditional joint revenue sharing arrangements

     22       —    

New hybrid joint revenue sharing lease arrangements

     8       2  
  

 

 

   

 

 

 

Total new theaters

     45       38  

Upgrades of IMAX theater systems

     —         1  
  

 

 

   

 

 

 

Total Theater Signings

     45       39  
  

 

 

   

 

 

 
     Three Months
Ended March 31,
 
     2018     2017  

Theater Installations:

    

Full new sales and sales-type lease arrangements

     13       5  

New traditional joint revenue sharing arrangements

     3       8  

New hybrid joint revenue sharing lease arrangements

     —         1  
  

 

 

   

 

 

 

Total new theaters

     16       14  

Upgrades of IMAX theater systems

     —         1 (1) 
  

 

 

   

 

 

 

Total Theater Installations

     16       15  
  

 

 

   

 

 

 
     Three Months
Ended March 31,
 
     2018     2017  

Theater Backlogs:

    

New sales and sales-type lease arrangements

     178 (2)      176  

New joint revenue sharing arrangements

    

Hybrid lease arrangements

     116       93  

Traditional arrangements

     235       255  
  

 

 

   

 

 

 

Total Theater Backlog

     529 (3)      524 (4) 
  

 

 

   

 

 

 
     Three Months
Ended March 31,
 
     2018     2017  

Theater Network:

    

Commercial Multiplex Theaters:

    

Sales and sales-type lease arrangements

     568       472  

Traditional joint revenue sharing arrangements

     610       533  

Hybrid joint revenue sharing lease arrangements

     108       116  
  

 

 

   

 

 

 

Total Commercial Multiplex Theaters

     1,286       1,121  

Commercial Destination Theaters

     12       14  

Institutional Theaters

     84       91  
  

 

 

   

 

 

 

Total Theater Network

     1,382       1,226  
  

 

 

   

 

 

 

 

(1) Includes one installation of an upgrade to a laser-based digital system under a sales arrangement.
(2) Includes 14 theater systems which were previously classified under joint revenue sharing arrangements – hybrid sales arrangements.
(3) Includes 33 laser-based digital theater system configurations, including five upgrades.
(4) Includes 21 laser-based digital theater system configurations, including three upgrades.

 

5


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands of U.S. dollars, except per share amounts)

(Unaudited)

 

     Three Months Ended
March 31,
 
     2018     2017  

Revenues

    

Equipment and product sales

   $ 19,513     $ 11,544  

Services

     44,746       38,844  

Rentals

     18,202       15,857  

Finance income

     2,523       2,412  
  

 

 

   

 

 

 
     84,984       68,657  
  

 

 

   

 

 

 

Costs and expenses applicable to revenues

    

Equipment and product sales

     7,972       7,464  

Services

     20,351       19,814  

Rentals

     5,969       5,608  
  

 

 

   

 

 

 
     34,292       32,886  
  

 

 

   

 

 

 

Gross margin

     50,692       35,771  

Selling, general and administrative expenses
(including share-based compensation expense of $4.4 million for the three months ended March 31, 2018 (2017 — $5.3 million))

     28,083       30,941  

Research and development

     3,592       4,334  

Amortization of intangibles

     892       602  

Receivable provisions, net of recoveries

     451       185  

Exit costs, restructuring charges and associated impairments

     702       —    
  

 

 

   

 

 

 

Income (loss) from operations

     16,972       (291

Interest income

     247       228  

Interest expense

     (494     (455
  

 

 

   

 

 

 

Income (loss) from operations before income taxes

     16,725       (518
  

 

 

   

 

 

 

Provision for income taxes

     (4,453     (114

Loss from equity-accounted investments, net of tax

     (205     (255
  

 

 

   

 

 

 

Net income (loss)

     12,067       (887

Less: net (income) loss attributable to non-controlling interests

     (3,562     962  
  

 

 

   

 

 

 

Net income attributable to common shareholders

   $ 8,505     $ 75  
  

 

 

   

 

 

 

Net income per share attributable to common shareholders—basic and diluted:

 

 

Net income per share — basic and diluted

   $ 0.13     $ —    
  

 

 

   

 

 

 

Weighted average number of shares outstanding (000’s):

    

Basic

     64,555       66,363  

Fully Diluted

     64,619       67,180  

Additional Disclosure:

    

Depreciation and amortization(1)

   $ 13,521     $ 12,088  

 

(1) Includes $0.1 million of amortization of deferred financing costs charged to interest expense for the three months ended March 31, 2018 (2017—$0.1 million).

 

6


IMAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of U.S. dollars)

(Unaudited)

 

     March 31,
2018
    December 31,
2017
 

Assets

    

Cash and cash equivalents

   $ 145,579     $ 158,725  

Accounts receivable, net of allowance for doubtful accounts of $2,075 (December 31, 2017 — $1,613)

     119,754       130,546  

Financing receivables

     129,774       129,494  

Inventories

     29,096       30,788  

Prepaid expenses

     10,165       7,549  

Film assets

     7,714       5,026  

Property, plant and equipment

     278,978       276,781  

Other assets

     62,569       26,757  

Deferred income taxes

     25,145       30,708  

Other intangible assets

     30,533       31,211  

Goodwill

     39,027       39,027  
  

 

 

   

 

 

 

Total assets

   $ 878,334     $ 866,612  
  

 

 

   

 

 

 

Liabilities

    

Bank indebtedness

   $ 24,867     $ 25,357  

Accounts payable

     13,782       24,235  

Accrued and other liabilities

     94,023       100,140  

Deferred revenue

     112,131       113,270  
  

 

 

   

 

 

 

Total liabilities

     244,803       263,002  
  

 

 

   

 

 

 

Commitments and contingencies

    

Non-controlling interests

     5,471       1,353  
  

 

 

   

 

 

 

Shareholders’ equity

    

Capital stock common shares — no par value. Authorized — unlimited number.
64,287,977 issued and 63,996,413 outstanding (December 31, 2017 — 64,902,201 issued and 64,695,550 outstanding)

     441,303       445,797  

Less: Treasury stock, 291,564 shares at cost (December 31, 2017 — 206,651)

     (5,992     (5,133

Other equity

     173,866       175,300  

Accumulated deficit

     (60,418     (87,592

Accumulated other comprehensive loss

     (138     (626
  

 

 

   

 

 

 

Total shareholders’ equity attributable to common shareholders

     548,621       527,746  

Non-controlling interests

     79,439       74,511  
  

 

 

   

 

 

 

Total shareholders’ equity

     628,060       602,257  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 878,334     $ 866,612  
  

 

 

   

 

 

 

 

7


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands of U.S. dollars)

(Unaudited)

 

     Three Months Ended March 31,  
     2018     2017  

Cash provided by (used in):

    

Operating Activities

    

Net income (loss)

   $ 12,067     $ (887

Adjustments to reconcile net income to cash from operations:

    

Depreciation and amortization

     13,521       12,088  

Write-downs, net of recoveries

     1,036       4,010  

Change in deferred income taxes

     (465     (958

Stock and other non-cash compensation

     5,141       5,660  

Unrealized foreign currency exchange loss (gain)

     35       (171

Loss from equity-accounted investments

     106       156  

Loss on non-cash contribution to equity-accounted investees

     99       99  

Investment in film assets

     (6,259     (3,334

Changes in other non-cash operating assets and liabilities

     (9,818     (17,280
  

 

 

   

 

 

 

Net cash provided by (used in) operating activities

     15,463       (617
  

 

 

   

 

 

 

Investing Activities

    

Purchase of property, plant and equipment

     (6,588     (4,068

Investment in joint revenue sharing equipment

     (4,810     (7,547

Acquisition of other intangible assets

     (555     (1,591

Investment in new business ventures

     —         (1,000
  

 

 

   

 

 

 

Net cash used in investing activities

     (11,953     (14,206
  

 

 

   

 

 

 

Financing Activities

    

Increase in bank indebtedness

     —         —    

Repayment of bank indebtedness

     (500     (500

Repurchase of common shares

     (13,396     —    

Treasury stock purchased for future settlement of restricted share units

     (5,992     (779

Taxes withheld and paid on employee stock awards vested

     (1,028     (146

Settlement of restricted share units and options

     (173     (11,158

Issuance of subsidiary shares to a non-controlling interest

     4,449       —    

Common shares issued—stock options exercised

     —         13,082  
  

 

 

   

 

 

 

Net cash (used in) provided by financing activities

     (16,640     499  
  

 

 

   

 

 

 

Effects of exchange rate changes on cash

     (16     46  
  

 

 

   

 

 

 

Decrease in cash and cash equivalents during period

     (13,146     (14,278

Cash and cash equivalents, beginning of period

     158,725       204,759  
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 145,579     $ 190,481  
  

 

 

   

 

 

 

 

8


IMAX CORPORATION

SELECTED FINANCIAL DATA

In accordance with United States Generally Accepted Accounting Principles

(in thousands of U.S. dollars)

The Company has four primary reporting groups identified by nature of product sold or service provided: (1) Network Business, representing variable revenue generated by box-office results and which includes the reportable segments of IMAX DMR and contingent rent from the JRSAs and IMAX systems segments; (2) Theater Business, representing revenue generated by the sale and installation of theater systems and maintenance services, primarily related to the IMAX Systems and Theater System Maintenance reportable segments, and also includes fixed hybrid revenues and upfront installation costs from the JRSA segment; (3) New Business, which includes content licensing and distribution fees associated with our original content investments, virtual reality initiatives, IMAX Home Entertainment, and other business initiatives that are in the development and/or start-up phase, and (4) Other; which includes the film post-production and distribution segments and certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.

 

     Three Months
Ended March 31,
 
     2018     2017  

Revenue

    

Network Business

    

IMAX DMR

   $ 27,051     $ 23,408  

Joint revenue sharing arrangements – contingent rent

     17,861       15,233  

IMAX systems – contingent rent

     —         688  
  

 

 

   

 

 

 
     44,912       39,329  
  

 

 

   

 

 

 

Theater Business

    

IMAX systems

    

Sales and sales-type leases

     18,138       6,942  

Ongoing fees and finance income

     2,730       2,585  

Joint revenue sharing arrangements – fixed fees

     —         470  

Theater system maintenance

     12,712       11,045  

Other theater

     1,377       2,165  
  

 

 

   

 

 

 
     34,957       23,207  
  

 

 

   

 

 

 

New Business

     608       1,280  
  

 

 

   

 

 

 

Other

    

Film distribution and post-production

     3,734       3,584  

Other

     773       1,257  
  

 

 

   

 

 

 
     4,507       4,841  
  

 

 

   

 

 

 

Total

   $ 84,984     $ 68,657  
  

 

 

   

 

 

 

Gross margin

    

Network Business

    

IMAX DMR(1)

   $ 18,782     $ 17,467  

Joint revenue sharing arrangements – contingent rent(1)

     12,740       10,250  

IMAX systems – contingent rent

     —         688  
  

 

 

   

 

 

 
     31,522       28,405  
  

 

 

   

 

 

 

Theater Business

    

IMAX systems

    

Sales and sales-type leases

     11,609       3,220  

Ongoing fees and finance income

     2,683       2,521  

Joint revenue sharing arrangements – fixed fees(1)

     —         88  

Theater system maintenance

     6,205       4,249  

Other theater

     (45     430  
  

 

 

   

 

 

 
     20,452       10,508  
  

 

 

   

 

 

 

New Business

     (1,469     (337
  

 

 

   

 

 

 

Other

    

Film distribution and post-production(1)

     446       (2,663

Other

     (259     (142
  

 

 

   

 

 

 
     187       (2,805
  

 

 

   

 

 

 

Total

   $ 50,692     $ 35,771  
  

 

 

   

 

 

 

 

9


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Non-GAAP Financial Measures:

In this release, the Company presents adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share, EBITDA and adjusted EBITDA as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) on net income. In addition, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share because it believes that they are important supplemental measures of its comparable financial results and could potentially distort the analysis of trends in business performance and it wants to ensure that its investors fully understand the impact of net income attributable to non-controlling interests and its stock-based compensation (net of any related tax impact) in determining net income attributable to common shareholders. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share should be considered in addition to, and not as a substitute for, net income and net income attributable to common shareholders and other measures of financial performance reported in accordance with U.S. GAAP.

The Company is required to maintain a minimum level of “EBITDA”, as such term is defined in the Company’s credit agreement (and which is referred to herein as “Adjusted EBITDA”, as the credit agreement includes additional adjustments beyond interest, taxes, depreciation and amortization). EBITDA and Adjusted EBITDA (each as defined below) should not be construed as substitutes for net income or as better measures of liquidity as determined in accordance with U.S. GAAP. The Company believes that EBITDA and Adjusted EBITDA are relevant and useful information widely used by analysts, investors and other interested parties in the Company’s industry.

 

     For the
3 months ended
March 31, 2018
    For the
12 months ended
March 31, 2018(1)
 
(In thousands of U.S. Dollars)             

Net income

   $ 12,067     $ 25,472  

Add (subtract):

    

Provision for income taxes

     4,453       21,129  

Interest expense, net of interest income

     247       935  

Depreciation and amortization, including film asset amortization

     13,380       67,668  
  

 

 

   

 

 

 

EBITDA

   $ 30,147     $ 115,204  

Stock and other non-cash compensation

     5,141       23,199  

Write-downs, net of recoveries including asset impairments and receivable provisions

     1,036       21,041  

Exit costs, restructuring charges and associated impairments

     702       16,876  

Loss from equity accounted investments

     205       653  
  

 

 

   

 

 

 

Adjusted EBITDA before non-controlling interests(2)

   $ 37,231     $ 176,973  

Adjusted EBITDA attributable to non-controlling interests

     (5,824     (25,906
  

 

 

   

 

 

 

Adjusted EBITDA per Credit Facility

   $ 31,407   $ 151,067
  

 

 

   

 

 

 

Adjusted EBITDA per Credit Facility, excluding impact from “Marvel’s Inhumans

   $ 31,463   $ 139,047
  

 

 

   

 

 

 

Adjusted revenues attributable to common shareholders

   $ 75,958     $ 353,698  
  

 

 

   

 

 

 

Adjusted EBITDA margin, excluding impact from “Marvel’s Inhumans

     41.3     42.7
  

 

 

   

 

 

 

Adjusted EBITDA per Credit Facility of $31.4 million and $151.1 million for the three and twelve months ended March 31, 2018 respectively, include the impact of the Company’s investment in “Marvel’s Inhumans”, which resulted in a $0.1 million and $13.0 million loss, respectively. However, as permitted by the Credit Facility, this loss was offset by addbacks of $nil and $13.3 million for amortization and by addbacks of, $nil and $11.7 million for impairment charges relating to the investment, in each case for the three and twelve months ended March 31, 2018, respectively. The net effect of these addbacks was to increase Adjusted EBITDA per Credit Facility by $0.1 million and $12.0 million for the three and twelve months ended March 31, 2018, respectively. This investment represents the Company’s first foray into a commercial television property, and therefore the Adjusted EBITDA per Credit Facility metric presented above may not be reflective of the Company’s typical operational activity. Further, the Company does not yet know whether it will make similar investments in the future. As a result, the Company is also presenting Adjusted EBITDA per Credit Facility excluding the impact of “Marvel’s Inhumans” to better facilitate comparisons to prior and future periods.

 

(1) Ratio of funded debt calculated using twelve months ended Adjusted EBITDA.

 

10


(2) The Adjusted EBITDA calculation specified for purpose of the minimum Adjusted EBITDA covenant excludes the reduction in Adjusted EBITDA from the Company’s non-controlling interests.

 

          3 months ended March 31, 2018     12 months ended March 31, 2018  

(3)

       
  

Total revenues

     $ 84,984       $ 397,094  
  

Greater China revenues

   $ 28,146       $ 136,030    
           
  

Non-controlling interest ownership percentage(4)

     32.07       31.90  
     

 

 

     

 

 

   
  

Deduction for non-controlling interest share of revenues

       (9,026       (43,396
       

 

 

     

 

 

 
  

Adjusted revenues attributable to common shareholders

     $ 75,958       $ 353,698  
       

 

 

     

 

 

 

 

(4) Weighted average ownership percentage for change in non-controlling interest share

 

11


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended March 31, 2018 vs. 2017:

The Company reported net income of $12.1 million, which calculates to $0.19 per basic and diluted share, for the first quarter of 2018 as compared to a net loss of $0.9 million, or $0.01 per basic and diluted share for the first quarter of 2017. Net income for the first quarter of 2018 includes a $4.8 million charge, or $0.08 per diluted share (2017 — $5.3 million or $0.08 per diluted share), for stock-based compensation and a $0.7 million charge, or $0.01 per diluted share (2017—$nil), for exit costs, restructuring charges and associated impairments. Adjusted net income, which consists of net income excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments and the related tax impact, was $17.1 million, or $0.27 per diluted share, for the first quarter of 2018 as compared to adjusted net income of $3.0 million, or $0.05 per diluted share, for the first quarter of 2017. The Company reported net income attributable to common shareholders of $8.5 million, or $0.13 per basic and diluted share for the first quarter of 2018 (2017 — $0.1 million or $nil per basic and diluted share). Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments and the related tax impact, was $13.4 million, or $0.21 per diluted share, for the first quarter of 2018 as compared to adjusted net income attributable to common shareholders of $3.9 million, or $0.06 per diluted share, for the first quarter of 2017. A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below:

 

     Quarter Ended March 31,  
  

 

 

 
(In thousands of U.S. dollars, except per share amounts)    2018     2017  
     Net Income     Diluted EPS     Net Income     Diluted EPS  

Reported net income

   $ 12,067     $ 0.19     $ (887   $ (0.01

Adjustments:

        

Stock-based compensation

     4,847       0.08       5,264       0.08  

Exit costs, restructuring charges and associated impairments

     702       0.01       —         —    

Tax impact on items listed above

     (559     (0.01     (1,341     (0.02
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted net income

     17,057       0.27       3,036       0.05  

Net (income) loss attributable to non-controlling interests

     (3,562     (0.06     962       0.01  

Stock-based compensation (net of tax of less than $0.1 million and less than $0.1 million, respectively)

     (57     —         (128     —    
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted net income attributable to common shareholders

   $ 13,438     $ 0.21     $ 3,870     $ 0.06  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average diluted shares outstanding

       64,619         67,180  
    

 

 

     

 

 

 

 

12


Free Cash Flow:

Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company’s after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:

 

     For the
Three months ended
March 31, 2018
 
(In thousands of U.S. Dollars)       

Net cash provided by operating activities

   $ 15,463  

Net cash used in investing activities

     (11,953
  

 

 

 

Net cash flow

   $ 3,510  
  

 

 

 

 

13